Lantern Pharma Inc. Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Lantern Pharma Inc. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2022-03-31 was $267.00K, a 8.75% increase year-over-year.
- Lantern Pharma Inc. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2021-09-30 was $224.41K, a 415.73% increase year-over-year.
- Lantern Pharma Inc. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2021-06-30 was $245.68K, a 133.18% increase year-over-year.
- Lantern Pharma Inc. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2021-03-31 was $245.52K, a 1230.01% increase year-over-year.
- Lantern Pharma Inc. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2021 was $961.54K, a 19.35% decline from fiscal 2020.
- Lantern Pharma Inc. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2020 was $1.19M, a 912.43% increase from fiscal 2019.
- Lantern Pharma Inc. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2019 was $117.76K.
| Period end | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 3 month | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 12 month |
|---|---|---|
| 2022-03-31 | $267.00K 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $961.54K 10-K · filed 2022-03-10 | |
| 2021-09-30 | $224.41K 10-Q · filed 2021-11-01 | |
| 2021-06-30 | $245.68K 10-Q · filed 2021-11-01 | |
| 2021-03-31 | $245.52K 10-Q · filed 2022-05-03 | |
| 2020-12-31 | $1.19M 10-K · filed 2022-03-10 | |
| 2020-09-30 | $43.51K 10-Q · filed 2021-11-01 | |
| 2020-06-30 | $105.36K 10-Q · filed 2021-11-01 | |
| 2020-03-31 | $18.46K 10-Q · filed 2021-11-01 | |
| 2019-12-31 | $117.76K 10-K · filed 2021-03-10 | |
| 2019-09-30 | $32.80K 10-Q · filed 2020-10-29 | |
| 2019-06-30 | $6.03K 10-Q · filed 2020-10-29 | |
| 2019-03-31 | $15.53K 10-Q · filed 2020-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |